IDH1 and neoplasm: Assignment of IDH-mutated (defined by IDH1 R132 or IDH2 R172 mutations), 1p/19q and TERT promoter mutation (defined by C228T or C250T) status in tumours was determined using conventional sequencing and single-nucleotide polymorphism (SNP) array methods.